BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 3825005)

  • 1. [A complex vaccine in the prevention of staphylococcal, Pseudomonas aeruginosa and Proteus infections in esophageal cancer patients].
    Kochetkova VA; Moskovtseva RL; Mamontov AS
    Vopr Onkol; 1987; 33(2):58-63. PubMed ID: 3825005
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Changes in the anti-infection immunity indices of esophageal cancer patients undergoing combined immunization against staphylococcal and Pseudomonas aeruginosa infections].
    Kochetkova VA; Mamontov AS; Sokolova II; Mezhova OM; Morozov AF
    Zh Mikrobiol Epidemiol Immunobiol; 1982 Jun; (6):91-5. PubMed ID: 6810593
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Assessment of the prophylactic activity of staphylococcal anatoxin and Proteus vaccine in the combined treatment of patients with trauma to the locomotor system].
    Zdanovskaia LK; Kliukvin IIu; Bulava GV; Levina LA; Kaverina KG
    Ortop Travmatol Protez; 1989 Sep; (9):37-41. PubMed ID: 2594344
    [No Abstract]   [Full Text] [Related]  

  • 4. [Infection and immunity in burns].
    Kolker II
    Khirurgiia (Mosk); 1980 May; (5):17-22. PubMed ID: 6772869
    [No Abstract]   [Full Text] [Related]  

  • 5. Endotracheal gentamicin for the prevention of bronchial infections in patients with tracheotomy.
    Klastersky J; Cappel R; Noterman J; Snoeck J; Geuning C; Mouawad E
    Int J Clin Pharmacol; 1973 Jul; 7(4):279-86. PubMed ID: 4199250
    [No Abstract]   [Full Text] [Related]  

  • 6. Active immunization of burned patients with a new multivalent Staphylococcus-Pseudomonas vaccine.
    Sachs A
    Prog Immunobiol Stand; 1971; 5():428-32. PubMed ID: 4633971
    [No Abstract]   [Full Text] [Related]  

  • 7. [Combined Staphylococcus-Proteus-Pseudomonas vaccine. II. The toxicity of the vaccine in "chronic" experiments and its ability to protect animals against Proteus and Staphylococcus infections].
    Kreĭnin LS; Egorova NB; Stanislavskiĭ ES; Kaverina KG; Levina LA
    Zh Mikrobiol Epidemiol Immunobiol; 1983 May; (5):87-92. PubMed ID: 6410625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Role of immunotherapy in the treatment of suppurative mediastinitis].
    Abakumov MM; Pogodina AN; Grigor'ev NI; Titova TI; Sidorova TN
    Vestn Khir Im I I Grek; 1984 Mar; 132(3):13-6. PubMed ID: 6426117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Problem of prevention of septic complications in burns].
    Klimenko LF; Riabaia RD
    Klin Khir (1962); 1980 Mar; (3):42-4. PubMed ID: 6768926
    [No Abstract]   [Full Text] [Related]  

  • 10. [Immunologic prevention of postoperative suppurative-inflammatory complications in cancer of the stomach].
    Kochetkova VA; Vashakmadze LA; Zarkua ZP
    Sov Med; 1986; (12):23-7. PubMed ID: 3563701
    [No Abstract]   [Full Text] [Related]  

  • 11. [Immunologic prevention and treatment of wound infection in open fractures and osteomyelitis].
    Bialik IF; Burdyga FA; Grigor'ev NI; Krokhina MA; Kalashnik AF
    Ortop Travmatol Protez; 1981 Aug; (8):17-21. PubMed ID: 6793953
    [No Abstract]   [Full Text] [Related]  

  • 12. Pseudomonas aeruginosa: prevention better than cure?
    Mellor JA; Miler JJ
    Dev Biol Stand; 1979; 43():53-9. PubMed ID: 118071
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [The strategy against post-operative infection in the patients with esophageal cancer].
    Mizote H; Hikita S; Yoshida S; Katsuki N; Fujita H; Kakegawa T
    Gan To Kagaku Ryoho; 1992 Feb; 19(2):167-72. PubMed ID: 1736830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Initial experience with prophylactic Proteus vaccine immunization in an emergency clinic].
    Zdanovskaia LK; Kliukvin IIu; Bulava GV; Kreĭnin LS; Levina LA; Kaverina KG
    Klin Med (Mosk); 1990 Nov; 68(11):75-7. PubMed ID: 2283824
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Immunological activity of a Proteus vaccine administered to volunteers simultaneously with a pyoimmunogen and adsorbed staphylococcal anatoxin].
    Levina LA; Iurova VA; Kreĭnin LS; Kaverina KG; Dubova VG
    Zh Mikrobiol Epidemiol Immunobiol; 1987 Dec; (12):57-61. PubMed ID: 3128030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Early protection by vaccines in burns.
    Jones RJ
    Br J Exp Pathol; 1971 Feb; 52(1):100-9. PubMed ID: 4993954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Antibody titer in surgical patients immunized with staphylococcal anatoxin].
    Proskurov VA; Snisarenko AV
    Vestn Khir Im I I Grek; 1971 Mar; 106(3):8-9. PubMed ID: 5087529
    [No Abstract]   [Full Text] [Related]  

  • 18. Application of vaccine technology to prevention of Pseudomonas aeruginosa infections.
    Pier G
    Expert Rev Vaccines; 2005 Oct; 4(5):645-56. PubMed ID: 16221066
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Preventive properties of the blood sera from persons vaccinated with a Proteus vaccine made from soluble antigen complexes].
    Levina LA; Kreĭnin LS; Kaverina KG; Zdanovskaia LK; Iurova VA
    Zh Mikrobiol Epidemiol Immunobiol; 1986 Apr; (4):84-8. PubMed ID: 3087123
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Experience in the use of staphylococcal anatoxin in pediatric surgery].
    Snopkova VA; Bilich GL
    Vopr Okhr Materin Det; 1966 Jan; 11(1):84-7. PubMed ID: 5986386
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.